Literature DB >> 10550582

Chemotherapy for low-grade gliomas.

A T Reddy1, R J Packer.   

Abstract

Low-grade gliomas are the most common histological type of pediatric brain tumor. They can arise in any part of the nervous system. Although low-grade gliomas are slow growing, they often recur or progress, especially in areas such as the diencephalon or brain stem, where resection is limited by proximity to vital and eloquent structures. Radiation has been used to treat progressive low-grade gliomas, but it is not clear that it improves long-term outcome. Radiotherapy also has potential significant cognitive, endocrine, and vascular side- effects. There is a growing body of evidence to suggest that chemotherapy can delay and may obviate the need for radiation therapy or aggressive surgery. This chapter reviews the published chemotherapeutic trials. Chemotherapy appears to have a major role in the management of children with progressive low-grade gliomas.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10550582     DOI: 10.1007/s003810050539

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  20 in total

1.  Randomized study of two chemotherapy regimens for treatment of low-grade glioma in young children: a report from the Children's Oncology Group.

Authors:  Joann L Ater; Tianni Zhou; Emiko Holmes; Claire M Mazewski; Timothy N Booth; David R Freyer; Ken H Lazarus; Roger J Packer; Michael Prados; Richard Sposto; Gilbert Vezina; Jeffrey H Wisoff; Ian F Pollack
Journal:  J Clin Oncol       Date:  2012-06-04       Impact factor: 44.544

Review 2.  Pediatric surgical neuro-oncology: current best care practices and strategies.

Authors:  James T Rutka; John S Kuo
Journal:  J Neurooncol       Date:  2004 Aug-Sep       Impact factor: 4.130

3.  Quality of health information on the Internet in pediatric neuro-oncology.

Authors:  Darren R Hargrave; Ursula A Hargrave; Eric Bouffet
Journal:  Neuro Oncol       Date:  2006-03-02       Impact factor: 12.300

4.  Late sequela after treatment of childhood low-grade gliomas: a retrospective analysis of 69 long-term survivors treated between 1983 and 2003.

Authors:  Martin Benesch; Herwig Lackner; Petra Sovinz; Elisabeth Suppan; Wolfgang Schwinger; Hans-Georg Eder; Hans Jürgen Dornbusch; Andrea Moser; Karin Triebl-Roth; Christian Urban
Journal:  J Neurooncol       Date:  2006-04-25       Impact factor: 4.130

5.  Magnetic resonance imaging of ethyl-nitrosourea-induced rat gliomas: a model for experimental therapeutics of low-grade gliomas.

Authors:  P E Kish; M Blaivas; M Strawderman; K M Muraszko; D A Ross; B D Ross; G McMahon
Journal:  J Neurooncol       Date:  2001-07       Impact factor: 4.130

6.  Astrocytic tumors in children: treatment results from a single institution.

Authors:  Ali Varan; Canan Akyüz; Nejat Akalan; Lale Atahan; Figen Söylemezoglu; Ugur Selek; Bilgehan Yalçin; Tezer Kutluk; Münevver Büyükpamukçu
Journal:  Childs Nerv Syst       Date:  2006-10-13       Impact factor: 1.475

7.  Childhood brain tumour information on the Internet in the Chinese language.

Authors:  Loretta Lau; Darren R Hargrave; Ute Bartels; Carlos Esquembre; Eric Bouffet
Journal:  Childs Nerv Syst       Date:  2005-11-10       Impact factor: 1.475

Review 8.  Considerations on the role of chemotherapy and modern radiotherapy in the treatment of childhood low grade glioma.

Authors:  Giorgio Perilongo
Journal:  J Neurooncol       Date:  2005-12       Impact factor: 4.130

Review 9.  Optic pathway gliomas: a review.

Authors:  Iris Fried; Uri Tabori; Tarik Tihan; Arun Reginald; Eric Bouffet
Journal:  CNS Oncol       Date:  2013-03

Review 10.  Primary anaplastic pleomorphic xanthoastrocytoma with widespread neuroaxis dissemination at diagnosis--a pediatric case report and review of the literature.

Authors:  Toshiyuki Okazaki; Teruyoshi Kageji; Kazuhito Matsuzaki; Hidehisa Horiguchi; Takanori Hirose; Hiroyoshi Watanabe; Toshihiro Ohnishi; Shinji Nagahiro
Journal:  J Neurooncol       Date:  2009-03-27       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.